Models:
Joseph Gordon
joseph-gordon/
ClinicalTrialsElig
0
Downloads: 1
[c09aa8]: / clusters / clustall9k / 20.txt

Download this file

121 lines (120 with data), 6.7 kB 

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
Patients with GOG performance status of 3 or 4

Patients with GOG performance grade of 3 or 4

Patients with a GOG performance status of 0, 1, or 2

Have performance status of 0 or 1 on the GOG performance scale

Patients with GOG performance grade of 3 or 4

PHASE II: Patients must have a GOG performance status of 0, 1, or 2

Patients with a GOG Performance Status of 0, 1, or 2.

Gynecological Oncology Group (GOG) performance status =< 2

Patients who have received one prior regimen must have a GOG performance status of 0, 1 or 2; patients who have received two or more prior regimens must have GOG performance status of 0 or 1

Patients with GOG performance status of 3 or 4

Patients must have a GOG performance status of 0 or 1

Patients with GOG performance status of 2, 3 or 4; or ECOG performance status of 2, 3 or 4

Patients must have a GOG performance status of 0 or 1.

GOG performance status 0-2;

Patients with GOG performance grade of 3 or 4

Patients must have a GOG performance status of 0 or 1

Patients must have a Gynecological Oncology Group (GOG) performance status of 0, 1 or 2

Patients with a GOG performance status of grade 3 or 4 are not eligible

GOG performance status 0-2 (refer to Appendix A);

Patients with a GOG Performance Status of 0, 1, or 2

Patients with GOG performance grade of 3 or 4

GOG performance status > 2

Performance status 0, 1 or 2

WHO performance status of 0 or 1

Performance Status of 0, 1, or 2

Performance status of 0 or 1

Performance status of 0 or 1

Performance status 0-1.

Adequate Performance Status

Performance status =< 2

Patient has a WHO performance status 0-1

Performance status of 0-3

Performance status of 0, 1, or 2

Good performance status

Performance status of 0 to 3

Performance status =< 3

Performance status =< 1

Performance status of 0 or 1

Performance status of 0-3

Performance status of 0, 1, or 2

WHO Performance Status 0, 1 or 2. A maximum of 1/3 of patients in cohorts A & B may be WHO performance status 2

Must have adequate performance status:

Performance status of 0, 1, or 2

Performance status =< 2

Performance status 0-2

Performance status >= 60%

Performance status >= 2

Performance status will not be considered

Performance status =< 3

WHO performance status 0-1

Performance status 0-1

Performance status of 0 or 1

Performance Status:

Performance status 0-1

Kamofsky performance status ?70%

Performance Status 0-2;

Performance Status 0-1

Performance status must be 0-1.

Patients with any performance status are eligible for enrollment

WHO performance status of 3 or 4

Performance status 0 or 1

WHO performance status 0-2

Performance status >= 60%

Performance status 0-1

WHO performance status of ? 1

Performance status of 0, 1, or 2

Adequate performance status.

Adequate performance status, defined as:

Performance status:

Performance Status of 0 or 1

Performance Status of 0 or 1.

WHO performance status of 0-1

Performance Status of 0 or 1

WHO performance status of ? 2.

Performance Status of 0 or 1

WHO performance status 0-1.

Performance status 0-2

Acceptable level of performance status (both)

Performance status of 2 or better

Performance status of 0 - 1

Patients must have a performance status of 0-2

Performance status =< 1

Performance status 0 or 1

performance status of 0 or 1

Performance status as per protocol

Gynecologic Oncology Group (GOG) performance status 0, 1, 2

Patients must have Gynecologic Oncology Group (GOG) performance status 0, 1, or 2

Patients must not be eligible for a higher priority Gynecologic Oncology Group (GOG) protocol, if one exists; in general, this would refer to any active GOG Phase III protocol or Rare Tumor protocol for the same patient population

Patients must have a Gynecologic Oncology Group (GOG) performance grade of 0, 1, or 2

Gynecologic Oncology Group (GOG) performance status > 2

Gynecologic Oncology Group (GOG) or Eastern Cooperative Oncology Group (ECOG) performance status =< 1 or Karnofsky scale (KPS) =< 70%

Eastern Cooperative Oncology Group (ECOG) (World Health Organization [WHO]/Gynecologic Oncology Group [GOG]/Zubrod score) performance status 0 - 2

Patients must have a Gynecologic Oncology Group (GOG) performance status of 0, 1, or 2

Gynecologic Oncology Group (GOG) performance status 0, 1, or 2

Patients must have Gynecologic Oncology Group (GOG) performance status 0, 1, or 2

Gynecologic Oncology Group (GOG) performance status =< 2

PHASE I: Patients must have a Gynecologic Oncology Groups (GOG) performance status of 0, 1, or 2

Unlimited number of prior treatment lines, provided Gynecologic Oncology Group (GOG)/Eastern Cooperative Oncology Group (ECOG) status is 0-1

Patients must have a Gynecologic Oncology Group (GOG) performance status of 0 or 1

Gynecologic Oncology Group (GOG) performance status =< 2

Gynecologic Oncology Group (GOG) Performance Status of 0, 1, or 2

Gynecologic Oncology Group (GOG) performance status >= 2

Gynecologic Oncology Group (GOG) performance status of 0 or 1

Patients must have a Gynecologic Oncology Group (GOG) performance status of 0-1

Patients must have a Gynecologic Oncology Group (GOG) performance status of 0, 1, or 2

Patients must have a Gynecologic Oncology Group (GOG) performance status of 0, 1, or 2

Patients must have a Gynecologic Oncology Group (GOG) performance status of 0, 1, or 2

Patients with Gynecologic Oncology Group (GOG) performance status of 3 or 4

Gynecologic Oncology Group (GOG) performance status of 0 to 1.

Patients must have a Gynecologic Oncology Group (GOG) performance status of 0, 1, or 2

Patients must not be eligible for a higher priority NRG clear cell protocol (Gynecologic Oncology Group [GOG]-0283); rare patients ineligible for GOG-0283 may be eligible for this trial without prior treatment on dasatinib therapy (e.g. they have been deemed allergic to dasatinib)

Gynecologic Oncology Group (GOG) performance status =< 2

Patients must have Gynecologic Oncology Group (GOG) performance status 0, 1, or 2

Patients must not be eligible for a higher priority Gynecologic Oncology Group (GOG) protocol, if one exists            \r\n* In general, this would refer to any active GOG phase III or rare tumor protocol for the same patient population

Patients must have a Gynecologic Oncology Group (GOG) performance status of 0, 1, or 2

Peritoneal dialysis catheter implantation is identical to that from the Gynecologic Oncology Group (GOG) 252 Protocol and revised from the GOG Surgical Procedures Manual

Patients must have a Gynecologic Oncology Group (GOG) performance status of 0, 1, or 2

Patient must have Gynecologic Oncology Group (GOG) performance status of 0, 1, or 2

Patients must have a Gynecologic Oncology Group (GOG) performance grade of 0, 1, or 2

Gynecologic Oncology Group (GOG) performance status =< 2